chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Injection site induration, Injection site pain, Injection site swelling, Injection site warmth, International normalised ratio
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Nausea, Prothrombin time, Pulmonary embolism, Pyrexia, Swelling
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Ultrasound scan normal, Vomiting
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Abdominal pain upper, Body temperature increased, Chest pain, Computerised tomogram abnormal, Dyspnoea
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Nausea
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 49.0
Sex: F
Vaccine: TDAP, TTOX
Symptoms: Pulmonary embolism, Scan with contrast abnormal, Vomiting
Clinical narrative: Initially pain at site followed with swelling and Headache. Next day, 2/17, additional swelling, induration, warm to touch along with nausea/vomiting and fever, dizziness and headache. 2/18: Same symptoms with Chest Pain now and call to 911 and brought to Hospital where she was worked up for Pulmonary embolus with CT Scan of chest and CT Angio of heart. Heart showed no disease.  CT chest Pulmonary showed Pulmonary Embolus. Treated with Lovenox and Coumadin and now placed on long term coumadin therapy. Back to work 3/11/10.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Quarter sized red spot at site of injection that was itchy.  Site of injection was L arm Subq
Age: 27.0
Sex: F
Vaccine: ANTH
Symptoms: Blood human chorionic gonadotropin increased, Drug exposure during pregnancy, No adverse event
Clinical narrative: Pt received AVA (4) prior to knowledge of pregnancy. Date of last normal menstrual period: 18 Apr 09. No adverse event / Received vaccine prior to knowing she was pregnant. Son was born on January 25th 2010. He was 22 inches long and weighed 9 lbs 1 oz. He has had two checkups with the pediatrician to date and so far he is completely healthy.
Age: 56.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Measles antibody positive, Mumps antibody test positive, Pyrexia, Rash
Clinical narrative: About 11-12 days after administration of subcu. MMR, employee developed measles from rash, fever, and marked cervical lymphadenopathy bilaterally. Fever did not exceed 100.2 degrees. Symptoms resolved within a week. 3/9/10-No noted problems.
Age: 56.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: About 11-12 days after administration of subcu. MMR, employee developed measles from rash, fever, and marked cervical lymphadenopathy bilaterally. Fever did not exceed 100.2 degrees. Symptoms resolved within a week. 3/9/10-No noted problems.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pyrexia, Rash generalised, Skin lesion
Clinical narrative: Fever and rash all over body. Skin lesions scattered on arms and legs.
Age: 1.02
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, HEPA, MMR, PNC, VARCEL
Symptoms: Rash, Upper respiratory tract infection
Clinical narrative: Pt had well baby check up 2/22/10 and administer MMR, VARICELLA, PREVNAR and HEPATITIS A vaccine (Had been seen 2/8/10 for cough, fever  seen 3/2/10 for "URI" low grade temp 100.2 @ home called 3/5/10 - "child with rash "afebrile" ?MMR reaction. called 3/7/10 rash persists - 3/8/10 seen in office.
Age: 1.02
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, HEPA, MMR, PNC, VARCEL
Symptoms: Laboratory test, Petechiae
Clinical narrative: Pt had well baby check up 2/22/10 and administer MMR, VARICELLA, PREVNAR and HEPATITIS A vaccine (Had been seen 2/8/10 for cough, fever  seen 3/2/10 for "URI" low grade temp 100.2 @ home called 3/5/10 - "child with rash "afebrile" ?MMR reaction. called 3/7/10 rash persists - 3/8/10 seen in office.
Age: 81.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Burning sensation, Pain in extremity, Rash erythematous
Clinical narrative: Pt reports she started having left thigh pain and burning the day she got the H1N1 vaccine 3/5/10. On 3/10/10 she developed a red, irregular rash on posterior left thigh and it is now spreading around to anterior thigh/groin area. Continues to have pain.
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Pain, Pyrexia, Tremor
Clinical narrative: Rec'd flu shot at about 2pm, 10/14/09. Pt called today 10/15 at 930A to report that he had a fever, chills and shakes, achiness the evening of 10/14. He did not call his Dr and did not take any medications. Did not take his temp. He reports that he started feeling better in the AM on 10/15/09. He denied any redness, itchiness or difficulty breathing.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus generalised, Rash erythematous
Clinical narrative: Rec'd Flu shot at about 115 p 10/14/09. Returned to clinic @ 245 p c/o itching (generalized) and red rash on upper chest & bilateral cheeks. Denied difficulty breathing. No SOB. Lung sounds clear, at 3 pm BP 150/98, P-108. Says she hasn't seen her Dr in along time and has no ph # nurse recommended visit to nearby urgent care. Pt declined. Reported that she has taken BENADRYL for previous allergies and would agree to take. She took BENADRYL 50 mg po. at 315 p BP 151/102 P - 97. At 335 p redness & itchiness diminished significantly: felt better. Agreed to call her Dr. Coworker to drive her home.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Blood pressure abnormal, Dizziness, Flushing, Musculoskeletal pain
Clinical narrative: Rec'd flu shot about 12:10 pm. Returned to clinic about 13:45 c/o achy shoulder, dizziness, nausea. Denied SOB. No apparent rash. Stated hx of migraines and H/A. BP 177/111 P=90. At 2 pm BP-148/93 P 84 T=97 degrees F at 2:18 pm BP 134/90 P=83 slight rash noted on neck and flushed cheeks. 2:40 BP 150/93 still feels weak and dizzy. Family member called to take to MD's office/other nurse onsite contacted MD office.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Rash
Clinical narrative: Rec'd flu shot about 12:10 pm. Returned to clinic about 13:45 c/o achy shoulder, dizziness, nausea. Denied SOB. No apparent rash. Stated hx of migraines and H/A. BP 177/111 P=90. At 2 pm BP-148/93 P 84 T=97 degrees F at 2:18 pm BP 134/90 P=83 slight rash noted on neck and flushed cheeks. 2:40 BP 150/93 still feels weak and dizzy. Family member called to take to MD's office/other nurse onsite contacted MD office.
Age: 0.3
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Body temperature increased, Diarrhoea, Vomiting
Clinical narrative: 4 days after second dose of Rotavirus vaccine baby developed diarrhea lasting 5 days then vomiting and T 101 degrees, no dehydration. Symptoms have resolved.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL, VARCEL
Symptoms: Injection site erythema, Injection site vesicles
Clinical narrative: Red blister like spots at injection site. Advised to use BENADRYL or CLAMIONE lotion.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL, VARCEL
Symptoms: Injection site reaction, Skin lesion
Clinical narrative: Red blister like spots at injection site. Advised to use BENADRYL or CLAMIONE lotion.
Age: 38.0
Sex: F
Vaccine: MMR
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site warmth, Pain
Clinical narrative: Concern/Data:Presents with local reaction to MMR injection received 03/09/10. Outer Upper Rt arm has firm, red, warm area size of palm. Tender to touch. Also, has body aches and headache. Symptoms started approximately 19:00 03/09/10. Has been taking Ibuprofen.
Age: 38.0
Sex: M
Vaccine: FLU(H1N1), FLUX
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives, pruritus
Age: 1.55
Sex: F
Vaccine: DTAP, FLU(H1N1), FLU3, HEPA, HIBV
Symptoms: Blood calcium, Blood magnesium, Computerised tomogram head, Convulsion, Eye movement disorder
Clinical narrative: Immunizations 3/2/10. Fever started 3/5/10 but cranky since shot. AM 3/6/10 with generalized seizure and transient Rt hemiparesis and gaze deviation. Hospitalized for observation after initial (-) workup.
Age: 1.55
Sex: F
Vaccine: DTAP, FLU(H1N1), FLU3, HEPA, HIBV
Symptoms: Full blood count, Hemiparesis, Influenza serology, Irritability, Metabolic function test
Clinical narrative: Immunizations 3/2/10. Fever started 3/5/10 but cranky since shot. AM 3/6/10 with generalized seizure and transient Rt hemiparesis and gaze deviation. Hospitalized for observation after initial (-) workup.
Age: 1.55
Sex: F
Vaccine: DTAP, FLU(H1N1), FLU3, HEPA, HIBV
Symptoms: Pyrexia, Respiratory syncytial virus test
Clinical narrative: Immunizations 3/2/10. Fever started 3/5/10 but cranky since shot. AM 3/6/10 with generalized seizure and transient Rt hemiparesis and gaze deviation. Hospitalized for observation after initial (-) workup.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Neuralgia, Paraesthesia, Pyrexia
Clinical narrative: Received shingles shot Jan 21, 2010.  On Feb 16 began to get an "electrical shock" sharp nerve pain in area of shot - under left arm.  * These continue at present, altho fever.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Diarrhoea, Similar reaction on previous exposure to drug
Clinical narrative: He received seasonal flu shot Fri 2/5/10. At 6:30pm he  had an episode of diarrhea. It started again the next morning and lasted until the following Friday. 8 days total with symptoms. He states he had similar reactions to seasonal flu shots in the military at age of 18,19 and 20.
Age: 83.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Fatigue, Presyncope, Pruritus, Rash
Clinical narrative: Stated she felt "wiped out" and almost passed out approx 1/2 hour after receiving H1N1 vaccine. She then experienced a rash on her face approx 3 days after receiving the vaccine. Itching accompanied the rash.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Right arm - right upper arm - red and swollen. Started 3/04/10 around 12:00pm. Area 16cm X 20 1/2 cm on upper right arm. Alternate ice and heat. Give BENADRYL - dose appropriate for wt. and MOTRIN
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Computerised tomogram normal, Convulsion, Full blood count normal, Metabolic function test
Clinical narrative: Rec'd vaccine at 15 mo. PE on 3-1-10. Exam unremarkable. On 3-4-10 had new onset seizure. Seen at ED - labs, CT head unremarkable.
Age: 43.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Swelling face
Clinical narrative: developed symptoms 03/04/10 a.m. Symptoms of swelling R side of face in front of ear R cervical lymph node swelling.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Skin exfoliation
Clinical narrative: Lt. Mid. arm has 4" circular redness + swelling at injection site - with a 1.5 cm. round area in middle of redness that appears to have had a peeling effect there is warmth in area. This occurred 48 m after injection.
Age: 47.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Back pain, Dizziness, Musculoskeletal stiffness, Nausea, Pain in extremity
Clinical narrative: 48 hours after vaccine patient started aching in back, light headed, nausea, vomiting. Pain worsened in mid back-bil hand/arm neck stiffness.
Age: 47.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Vomiting
Clinical narrative: 48 hours after vaccine patient started aching in back, light headed, nausea, vomiting. Pain worsened in mid back-bil hand/arm neck stiffness.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Rash generalised, Varicella post vaccine
Clinical narrative: Patient contracted VARICELLA.  Patient had body rash diagnosed as VARICELLA 3/1/10 after receiving both doses of VARICELLA vaccination.
Age: 3.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash generalised, Varicella post vaccine
Clinical narrative: Patient contracted Varicella. Patient had body rash diagnosed as Varicella 3/1/10 after receiving both doses of Varicella vaccination.
Age: 33.0
Sex: M
Vaccine: TD
Symptoms: Cellulitis, Drug administered at inappropriate site, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Client given IM Td into tricep instead of deltoid. Clients L tricep with pain, swelling and erythema 10cm x 9cm, inflammation vs cellulitis. 3/10/10 - Sx worsened. Seen in ER, IV ANCEF for cellulitis. Being treated with KEFLEX, BACTRIM added.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Varicella post vaccine
Clinical narrative: -patient contracted VARICELLA -patient had body rash diagnosed as VARICELLA 3/5/10 after receiving VARICELLA vaccination.
Age: 5.0
Sex: F
Vaccine: IPV, VARCEL
Symptoms: Erythema, Nodule
Clinical narrative: 5 yo shots 3/4/10 - saw on 3/5/10 describing large red knot documented by MD.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Facial paresis, Guillain-Barre syndrome, Hemiparesis, Hypoaesthesia, Hyporeflexia
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of Guillain Barre syndrome in a 36-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 14 October 2008 the subject received unspecified dose of FLUARIX (unknown). On 26 October 2008, 12 days after vaccination with FLUARIX, the subject experienced Guillain Barre syndrome, numbness and tingling. At an unspecified time after vaccination with FLUARIX, the subject experienced side weakness, left or right sided facial weakness, degenerative lumbar disc disease and decreased reflexes. The subject was admitted to the hospital with the diagnosis of right sided weakness. The subject began to experience symptoms of numbness and tingling in extremities on 26 October 2008. Treatment included IV fluids, IV immunoglobulin, brain MRI with and without contrast and lumbar puncture. No abnormalities of the brain were noted. Lumbar degenerative disc disease was present. History and physical noted ascending numbness decrease in reflexes and right-sided facial weakness. The subject was hospitalized on 06 November 2008. The subject was treated with intravenous fluid(s) and normal immunoglobulin. At the time of reporting the outcome of the Guillain Barre syndrome, side weakness, left or right sided facial weakness, numbness, tingling, degenerative lumbar disc disease and decreased reflexes was unspecified.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Immunoglobulin therapy, Intervertebral disc degeneration, Lumbar puncture abnormal, Nuclear magnetic resonance imaging brain normal, Paraesthesia
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of Guillain Barre syndrome in a 36-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 14 October 2008 the subject received unspecified dose of FLUARIX (unknown). On 26 October 2008, 12 days after vaccination with FLUARIX, the subject experienced Guillain Barre syndrome, numbness and tingling. At an unspecified time after vaccination with FLUARIX, the subject experienced side weakness, left or right sided facial weakness, degenerative lumbar disc disease and decreased reflexes. The subject was admitted to the hospital with the diagnosis of right sided weakness. The subject began to experience symptoms of numbness and tingling in extremities on 26 October 2008. Treatment included IV fluids, IV immunoglobulin, brain MRI with and without contrast and lumbar puncture. No abnormalities of the brain were noted. Lumbar degenerative disc disease was present. History and physical noted ascending numbness decrease in reflexes and right-sided facial weakness. The subject was hospitalized on 06 November 2008. The subject was treated with intravenous fluid(s) and normal immunoglobulin. At the time of reporting the outcome of the Guillain Barre syndrome, side weakness, left or right sided facial weakness, numbness, tingling, degenerative lumbar disc disease and decreased reflexes was unspecified.
Sex: M
Vaccine: HEPAB
Symptoms: Agitation, Deafness, Irritability
Clinical narrative: This case was reported by a healthcare professional via sales representative and described the occurrence of loss of hearing in a male subject of unspecified age who was vaccinated with TWINRIX (GlaxoSmithKline). Concurrent medical conditions included viral meningitis. Concurrent medications included Gabapentin. On 23 February 2010 the subject received 1st dose of TWINRIX (unknown, left arm). On 28 February 2010, 5 days after vaccination with TWINRIX, the subject experienced loss of hearing, increased irritability and increased agitation. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the loss of hearing, increased irritability and increased agitation was unspecified.
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Headache, Malaise, Skin warm
Clinical narrative: Day of vaccine-Arm & shoulder-red, and hot to touch. At-8pm-redness appears like a band around arm, also headache & malaise. 2 days post vaccine-03/11/10-physically feels better, but redness is still visible on arm & shoulder.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling, pain, warmth at injection site. Per patient, MD said it was an infection at injection site. Patient was given CIPRO 500mg and DICLOFENAC 75mg.
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: CSF protein increased, Electromyogram abnormal, Immunoglobulin therapy, Lumbar puncture, Muscular weakness
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs, approximately 1 week after receiving H1N1 vaccine patient has received 1 course 2gm/kg 1 IVIG.  Still being evaluated.  GBS mild.
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Nerve conduction studies abnormal, Pain in extremity
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs, approximately 1 week after receiving H1N1 vaccine patient has received 1 course 2gm/kg 1 IVIG.  Still being evaluated.  GBS mild.
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: CSF protein increased, Demyelinating polyneuropathy, Electromyogram abnormal, Immunoglobulin therapy, Lumbar puncture
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs, approximately 1 week after receiving H1N1 vaccine patient has received 1 course 2gm/kg 1 IVIG.  Still being evaluated.  GBS mild.
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Muscular weakness, Paraesthesia
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs, approximately 1 week after receiving H1N1 vaccine patient has received 1 course 2gm/kg 1 IVIG.  Still being evaluated.  GBS mild.
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: CSF protein increased, Electromyogram abnormal, Immunoglobulin therapy, Lumbar puncture, Muscular weakness
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs approximately 1 week after receiving H1N1 vaccine. Patient had received 1 course 2 gm/kg IVIG. Still being evaluated
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Nerve conduction studies abnormal, Pain in extremity
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs approximately 1 week after receiving H1N1 vaccine. Patient had received 1 course 2 gm/kg IVIG. Still being evaluated
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: CSF protein increased, Demyelinating polyneuropathy, Electromyogram abnormal, Immunoglobulin therapy, Lumbar puncture
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs approximately 1 week after receiving H1N1 vaccine. Patient had received 1 course 2 gm/kg IVIG. Still being evaluated
Age: 37.0
Sex: M
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Muscular weakness, Paraesthesia
Clinical narrative: The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs approximately 1 week after receiving H1N1 vaccine. Patient had received 1 course 2 gm/kg IVIG. Still being evaluated
Age: 37.0
Sex: M
Vaccine: FLU3, PPV, TD
Symptoms: Chills, Delirium, Pyrexia
Clinical narrative: Pt described high fever, delirium x 1 night, chills
Age: 3.0
Sex: F
Vaccine: TD
Symptoms: Injection site induration, Injection site pain, Tuberculin test
Clinical narrative: - Tender  and induration on right deltoid. treatment: KEFLEX 500 mg PO QTD.
Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Hives (small bumps) around injection. Site, down arms to hands and on back. Mom treated with BENADRYL with some relief. Spreading now to face (3/1/10).
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Burning sensation
Clinical narrative: I had burning all over especially in my hair. It felt as if my hair was on fire states patient.
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Chest pain
Clinical narrative: chest pain Follow-up: Called facility - patient rec'd tdap. They do not do SPV at their facility.
Age: 17.0
Sex: F
Vaccine: TD
Symptoms: Pruritus, Rash erythematous, Urticaria
Clinical narrative: small erythematous pruritic wheals on bilateral antecubital fossa and right forearm
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Abdominal pain, Crying, Flushing, Pain in extremity, Swelling
Clinical narrative: per mother, patient complained of foot pain, then abdominal pain, cried, got hives on trunk and face became flushed and swollen.  no vomiting, no respiratory symptoms
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: per mother, patient complained of foot pain, then abdominal pain, cried, got hives on trunk and face became flushed and swollen.  no vomiting, no respiratory symptoms
Age: 1.02
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Blood culture negative, Febrile convulsion, Full blood count normal, Influenza serology negative, Respiratory syncytial virus test negative
Clinical narrative: Febrile seizure of approximately one (1) minute duration the day after receiving routine immunizations for one year olds. Seen in local ER and released. As directed, parents gave Tylenol and Motrin afterwards.
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: Patient called next day on 03/10/2010 stating he got a bad headache that began 2 hours after shot was administered.  On 3/10/10 woke up with nausea and dizziness.  Patient advised to seek medical attention at PCP or ED.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Constipation, Electromyogram, Incontinence, Lumbar puncture, Neuropathy peripheral
Clinical narrative: Progressive weakness in both legs starting approximately 2 days after vaccination. Symptoms progressed to lower body paralysis. Patient was hospitalized about 6 weeks. Other symptoms: constipation, incontinence, peripheral neuropathy.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Paralysis
Clinical narrative: Progressive weakness in both legs starting approximately 2 days after vaccination. Symptoms progressed to lower body paralysis. Patient was hospitalized about 6 weeks. Other symptoms: constipation, incontinence, peripheral neuropathy.
Age: 38.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Laryngoscopy, Vocal cord paralysis
Clinical narrative: Paralysis of vocal cords for 39 days. Pt took steroids for decreased swelling of muscles in throat. Voice conts to come and go. Pt conts to flu with ENT.
Age: 25.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dysphagia, Headache, Pain, Pharyngeal oedema, Rash
Clinical narrative: 15 min after injection, pt reports she head headache, delayed swallowing, and felt like her throat was swollen. Pt DI DNOT REPORT SYMPTOMS AT THAT TIME. 45 mins. following shot, pt said her headache got worse vomited twice due to pain & took 400 mg Ibuprofen. Swallowing difficulties subsided & pt no longer felt related symptoms. At 1500 pt said rash around eyes & upper cheeks began and at this time went home. At 530 the next day, pt still felt symptoms listed above and took another 400 mg Ibuprofen. At 0940 pt. was seen at hospital ER.
Age: 25.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Vomiting
Clinical narrative: 15 min after injection, pt reports she head headache, delayed swallowing, and felt like her throat was swollen. Pt DI DNOT REPORT SYMPTOMS AT THAT TIME. 45 mins. following shot, pt said her headache got worse vomited twice due to pain & took 400 mg Ibuprofen. Swallowing difficulties subsided & pt no longer felt related symptoms. At 1500 pt said rash around eyes & upper cheeks began and at this time went home. At 530 the next day, pt still felt symptoms listed above and took another 400 mg Ibuprofen. At 0940 pt. was seen at hospital ER.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Anaphylactic reaction, Headache, Lymphadenopathy, Rash
Clinical narrative: Systemic reaction with rash on back and arms. Headache and lymphadenopathy.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Anaphylactic reaction, Rash
Clinical narrative: Systemic rxn. rash on back and upper extremity.
Age: 67.0
Sex: F
Vaccine: HEPA, IPV, MNQ, TYP, YF
Symptoms: Inappropriate schedule of drug administration, Pain, Swelling face, Urticaria
Clinical narrative: 3/19 Awoke morning after vaccinations with "bad hives" and body aches. Went to the ED was given Benadryl and told to take Benadryl at home. 3 days later (3/22) back to ER with continued symptoms and facial swelling. Given Benadryl, Pepcid and Prednisone with a RX for a 5 day taper. Symptoms resolved.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised
Clinical narrative: Patient called office on 3-4-10 to cancel 2nd GARDASIL vaccine secondary to C/o all over body rash after 1st vaccine. Patient's rash started on arms then progressed to legs. No itching. Symptoms x5 days. Spontaneous resolution. Pt did not use any medication for symptom relief.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Local reaction. 9x11 cm area of redness, swelling and itching at left shoulder.
Age: 0.51
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Chills, Pyrexia
Clinical narrative: After receiving H1N1 vaccine 1pm, pt had fever up to 104.5, chills.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Headache, Injection site erythema, Injection site mass, Injection site swelling, Pain
Clinical narrative: Left arm/bicep lump, redness, swelling. Patient reports fever 101.5 at home, headache, general achiness. Prescription written for Prednisone 3/11/10.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Left arm/bicep lump, redness, swelling. Patient reports fever 101.5 at home, headache, general achiness. Prescription written for Prednisone 3/11/10.
Age: 28.0
Sex: M
Vaccine: HEP
Symptoms: Ageusia, Ear pain, Facial palsy, Hypoaesthesia oral, Lacrimation increased
Clinical narrative: C/o numbness tongue, right eye tearing, facial droop, loss of taste, ear pain left side.
Age: 73.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Computerised tomogram, Injection site pain, Musculoskeletal pain, Nuclear magnetic resonance imaging, Paraesthesia
Clinical narrative: C/o pain in left deltoid and shoulder after receiving H1N1 injection. Ongoing pain in left arm. Had tingling in fingers/hands but that had resolved.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: 7 days after 3rd dose pt having dizzy episodes.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Hypoaesthesia facial, Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Pt reported localized reaction at site of injection (LA) (redness, swelling, heat, blisters) with onset about 48 hrs after vaccine administered. Pt also reported feeling of numbness in (L) shoulder, (L) side of neck and face.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site warmth
Clinical narrative: Pt reported localized reaction at site of injection (LA) (redness, swelling, heat, blisters) with onset about 48 hrs after vaccine administered. Pt also reported feeling of numbness in (L) shoulder, (L) side of neck and face.
Age: 12.0
Sex: F
Vaccine: FLU(H1N1), MNQ, TDAP, VARCEL
Symptoms: Headache, Inappropriate schedule of drug administration, Moaning, Muscle rigidity, Nausea
Clinical narrative: Started vaccinating with TDAP, then VARICELLA on L arm then moved on to R arm after H1N1 was admin, child began to get rigid, fists closed and tight and began to moan some what. Episode lasted for 30 sec to 1 min. approx. Instructed child to continue breathing and relax after episode child remained seated c/o nausea and headache. Instructed mother to call clinic if any other adverse events occur, voiced understanding.
Age: 40.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Injection site pain
Clinical narrative: Right arm became sore after about 1 week from the flu shot. I still have residual pain from upper shoulder down to my mid elbow.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthma, Influenza like illness
Clinical narrative: Flu like illness and exacerbation of asthma lasting > 1 week.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Eschar, Laboratory test normal, Lymphadenopathy
Clinical narrative: L sided supraclavicular lymphadenopathy.  Lasted 3 weeks after the eschar fell off.
Age: 8.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Acute disseminated encephalomyelitis, Lumbar puncture, Nuclear magnetic resonance imaging abnormal
Clinical narrative: ADEM.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Sensory disturbance
Clinical narrative: Sensation in arm, Arm still sore on 3/10/10, no swelling.
Age: 17.0
Sex: F
Vaccine: FLU(H1N1), FLUX, PPV, VARCEL
Symptoms: Cough, Nasal congestion, Rhinorrhoea
Clinical narrative: Upper respiratory symptoms (cough, nasal congestion, rhinorrhea) for 3 weeks
Age: 22.0
Sex: F
Vaccine: DTAP, HEPA, IPV, TYP, YF
Symptoms: Inappropriate schedule of drug administration, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Felt aches and fever. Mild but worsened. Fever was 101.5 degrees by 11:45 PM. Also had sore throat. Fever gone by 3/11/2010 morning, still sore throat at present (4:50Pm on 3/11). Aches almost entirely gone.
Age: 0.17
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, RV5, DTAP, HEP, HIBV, IPV, PNC, RV5
Symptoms: Death
Clinical narrative: He was put to bed but did not awaken at the usual time (about 2 AM) for feeding. It was then that mother found him in his bed,child was transported to the hospital.
Age: 18.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Asthenia, Electromyogram, Eyelid ptosis, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: Ptosis, weakness, numbness, dx of Guillain Barre syndrome, treated with IVIG.
Age: 18.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Immunoglobulin therapy, Lumbar puncture, Nerve conduction studies
Clinical narrative: Ptosis, weakness, numbness, dx of Guillain Barre syndrome, treated with IVIG.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site induration, Oedema peripheral, Skin warm
Clinical narrative: Swelling below injection site and warm to the touch.  Also the site is very ridged.
Age: 78.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abasia, Activities of daily living impaired, Back pain, Blood test, Chest X-ray
Clinical narrative: Severe back pain, unable to move or walk.  Could not use her breathing machine, pulmo-aid, was not able to do her breathing treatments with albuterol, so her emphysema got worse and she had to go to the hospital in December.  Then, in February she became ill with pneumonia, she had water in her lung because phlegm accumulated in her lung because she was not able to move. So, she had to go to the hospital again in February.
Age: 78.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Condition aggravated, Emphysema, Increased upper airway secretion, Pneumonia
Clinical narrative: Severe back pain, unable to move or walk.  Could not use her breathing machine, pulmo-aid, was not able to do her breathing treatments with albuterol, so her emphysema got worse and she had to go to the hospital in December.  Then, in February she became ill with pneumonia, she had water in her lung because phlegm accumulated in her lung because she was not able to move. So, she had to go to the hospital again in February.
Age: 35.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abortion induced, Abortion spontaneous, Drug exposure during pregnancy
Clinical narrative: Unclear if related:  3 weeks later diagnosed large posterior encephalocele (i.e. Neural Tube Defect) in 13th week of pregnancy.  ultrasound day of administration appeared normal.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Vaccine administered at 5:45pm on 3/10/10. About 8pm c/o pain, redness, swelling at injection site. Waited 24 hrs and got worse. Went to ER; diagnosed cellulitis. Rx Percocet (pain) and Cephalexin (antibiotic) given. Hospital staff said looked like given in tattoo, was actually given outside ink line.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: Pt experienced hive like rash on trunk and back.
Age: 11.0
Sex: M
Vaccine: DTAP, MNQ
Symptoms: Injection site erythema, Injection site oedema, Pallor
Clinical narrative: L deltoid red and slight edema surrounding 9x10cm. Blanching present 2 days after administration. Started cephalexin for 7 days.
Age: 45.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Cardiac disorder
Clinical narrative: Employee states the vaccine "bothered her heart" and she was in the ER, then discharged same day.
Age: 7.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Condition aggravated, Eyelid ptosis, Muscular weakness, Myasthenia gravis
Clinical narrative: A serious spontaneous report of Myasthenia Gravis manifested by exacerbation of droopy eyes and muscle weakness has been received from a parent/consumer concerning a seven-year-old male child, subsequent to H1N1, intranasal. At the time of the event, the patient had droopy eyes and muscle weakness. On 11-Dec-2009, the patient received H1N1, intranasal, for an unknown indication. After receiving H1N1 LAIV, his symptoms of droopy eyes and muscle weakness were exacerbated. In Feb-2010, it was found that patient had Myasthenia Gravis. The outcome for the reported adverse event was unknown at the time of reporting.
Age: 46.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Accidental exposure, Vision blurred
Clinical narrative: A serious spontaneous report of "inadvertent eye exposure to H1N1 LAIV" and "blurred vision has become exacerbated" has been received from a registered nurse/health professional concerning a 46-year-old male subsequent to H1N1 vaccine intranasal. Neither relevant medical history nor concomitant medication have been reported for this patient. On 26-Feb-2010 or 27-Feb-2010, the patient received the H1N1 vaccine, intranasal for an unknown indication. While vaccination, the patient inadvertently received a portion of the H1N1 LAIV dose in the eye. Immediately after inadvertent eye exposure, the patient started experiencing blurred vision. The blurred vision was exacerbated and was not resolved at the time of report. The outcome of "inadvertent eye exposure to H1N1 LAIV" was resolved while the outcome of "blurred vision has become exacerbated" was not resolved.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Fatigue, Hyperhidrosis, Myalgia, Nausea, Rash
Clinical narrative: Initial information received on 21 August 2009 from a health care professional. A 15 year old female patient with an unknown medical history received MENACTRA in the right deltoid (lot number U2917AA) on 14 August 2009. Illness at the time of vaccination was not reported. On 14 August 2009, 8-10 hours post vaccination, the patient developed diffuse myalgia, fatigue, sweating, and nausea which lasted 36 hours. On 17 August 2009 the patient developed a rash. Recovery status was not provided. No further information provided. Follow up information received on 13 October 2009 from a health care professional. The route of administration MENACTRA vaccine was intramuscular. The patient also received a first intramuscular injection in the left deltoid of GARDASIL (Merck and Co., lot number 00874) and on 14 August 2009. Illness at the time of vaccination was none. Other medications were reported as none. Follow-up information received on 16 November 2009 from a healthcare professional. The patient was seen by a physician on 17 August 2009. No laboratory or diagnostic tests were performed. The patient recovered by 21 August 2009.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Fatigue, Hot flush, Hyperhidrosis, Nausea, Pain
Clinical narrative: Initial information received on 21 August 2009 from a health care professional. A 15 year old female patient with an unknown medical history received MENACTRA in the right deltoid (lot number U2917AA) on 14 August 2009. Illness at the time of vaccination was not reported. On 14 August 2009, 8-10 hours post vaccination, the patient developed diffuse myalgia, fatigue, sweating, and nausea which lasted 36 hours. On 17 August 2009 the patient developed a rash. Recovery status was not provided. No further information provided. Follow up information received on 13 October 2009 from a health care professional. The route of administration MENACTRA vaccine was intramuscular. The patient also received a first intramuscular injection in the left deltoid of GARDASIL (Merck and Co., lot number 00874) and on 14 August 2009. Illness at the time of vaccination was none. Other medications were reported as none. Follow-up information received on 16 November 2009 from a healthcare professional. The patient was seen by a physician on 17 August 2009. No laboratory or diagnostic tests were performed. The patient recovered by 21 August 2009.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Urticaria
Clinical narrative: Initial information received on 21 August 2009 from a health care professional. A 15 year old female patient with an unknown medical history received MENACTRA in the right deltoid (lot number U2917AA) on 14 August 2009. Illness at the time of vaccination was not reported. On 14 August 2009, 8-10 hours post vaccination, the patient developed diffuse myalgia, fatigue, sweating, and nausea which lasted 36 hours. On 17 August 2009 the patient developed a rash. Recovery status was not provided. No further information provided. Follow up information received on 13 October 2009 from a health care professional. The route of administration MENACTRA vaccine was intramuscular. The patient also received a first intramuscular injection in the left deltoid of GARDASIL (Merck and Co., lot number 00874) and on 14 August 2009. Illness at the time of vaccination was none. Other medications were reported as none. Follow-up information received on 16 November 2009 from a healthcare professional. The patient was seen by a physician on 17 August 2009. No laboratory or diagnostic tests were performed. The patient recovered by 21 August 2009.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Papilloedema
Clinical narrative: An 18-year-old female patient, with no reported medical history, received an intramuscular right deltoid injection of MENACTRA (lot number U2919AA) on 30 July 2009. Three weeks post-vaccination, while undergoing a routine eye exam, she was noted to have a swollen optic nerve. Outcome was unknown. No additional information was reported. Follow-up information was received 24 September 2009 from a health care professional. The patient had no illness at the time of vaccination. She was seen by a neurologist who R/O MENACTRA being the cause of symptoms (specific symptoms not reported). According to the reporter, the patient recovered from the event. The date 11 August 2009 was entered in the seriousness criteria box of the VAERS form; however, it was not specified what this date represents. No additional information was provided at the time of the report. Follow-up information received 19 October 2009 from a health care professional. According to the reporter, the patient did not have any symptoms, but did have papilledema on ophthalmoscopic exam. The etiology was determined to be birth control pills. DIAMOX was prescribed as corrective treatment and birth control pills were stopped. At the time of the report, the patient had not recovered (previously reported as recovered). Follow-up information received 30 November 2009 from a health care professional. The reporter clarified that the patient had a doctor's visit on 11 August 2009. No additional information was provided. Follow-up information received 07 December 2009 from a health care professional. The patient continued to asymptomatic, though she had mild optic nerve papilledema. The reporter indicated there is no additional information at this time. Follow-up information received on 21 December 2009 from a health care professional. Per the reporter, the patient was taking birth control pills at the time of the vaccination on 30 July 2009; and that she still has optic nerve swelling. No further information is expected.
Sex: F
Vaccine: MNQ
Symptoms: Accidental exposure, Skin laceration
Clinical narrative: A female patient (age not specified) opened a small box of MENACTRA (lot number U2926AA) and as a result sustained a small cut on her left pink finger (date not provided). Two vials were broken into pieces. Initially the patient was reported as receiving one stitch, however additional information was received that stated the patient did not require stitched or antibiotics, just a bandage. the recovery status was not reported. No additional information was provided. List of Documents held by Sender: none.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Rash macular, Upper respiratory tract infection, Urticaria
Clinical narrative: Initial report received from a health care professional on 01 September 2009, at which time only non-serious listed events were reported. Follow-up information was received on 16 September 2009 which added an unlisted event; this narrative incorporates information from both versions. An 11-year0old male patient, with no reported medical history, received a right arm injection of MENACTRA lot number U3014AA) on 24 August 2009. Within 24 hours of vaccination, he developed an urticarial rash, redness, and swelling of the whole upper arm. He subsequently experienced blotchy urticaria on back and behind his ears, and also developed an upper respiratory infection. No cough or rhinorrhea were noted. The patient was seen by his physician, and treatment included Zyrtec and topical Benadryl. The events recovered on 01 September 2009.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Abdominal discomfort, Nausea, Rash maculo-papular, Rash pruritic
Clinical narrative: Initial report received on 03 September 2009 from a physician. A 12-year-old male patient, who is enrolled in a clinical trial for ADHD with a tricyclic investigational drug, but who has no known allergies, had received a dose of MENACTRA (lot number, route and site not reported) on 10 August 2009 (at an alternate facility) after being screened for a clinical trial and days prior to the patient being randomized and receiving a tricyclic investigational drug (which is in early phases of clinical development). Approximately 2-3 weeks after receiving MENACTRA, and an unknown number of days after receiving the tricyclic investigational drug, the patient developed pruritic maculo-papular rash on his feet and legs which migrated proximally to his face and scalp. He subsequently developed mid-epigastric abdominal discomfort and nausea (date not reported). The patient was treated with a MEDROL-dose pack for the rash which improved, but had not resolved at the time of this report. Per the reporter, the adverse events were assessed as being related to the study drug versus possible enteroviral gastroenteritis that was circulating in the area. At the time of this report, the patient had not recovered.
Age: 37.0
Sex: F
Vaccine: MNQ, PPV
Symptoms: Nausea, Neck pain, Pain, Pyrexia
Clinical narrative: A 37 year old female patient with acne (being treated with doxycycline) developed symptoms after receiving a first dose of MENACTRA (lot number U2874BA) in the right deltoid and a pneumonia vaccine (manufacturer not reported, lot number 0632Y) in the left deltoid on 22 September 2009 at 8:42 AM. At 6 PM, the patient developed a fever of 102 degrees, body aches, neck pain, and nausea. No other information was provided. The patient recovered. Follow-up information received 28 October 2009 from a health care professional. The pneumonia vaccine was manufactured by Merck, and both MENACTRA and pneumonia vaccines were administered intramuscularly. The event did not require a doctor's visit. When asked if the symptoms required treatment, or if the symptoms resolved on their own, the reporter replied "no". No additional information was provided. Follow-up information received on 16 November 2009 from a health care professional. The symptoms did not require treatment and persisted for two days. List of Documents held by Sender: none.